摘要
Introduction The global effect of alcohol-related liver disease(ALD)continues to climb.ALD is now the world’s leading etiology of cirrhosis,responsible for nearly 60%of cases of cirrhosis in Europe,North America,and Latin America(1).The COVID-19 pandemic has also increased the impact of ALD with significant increases in the number of admissions for alcohol-associated hepatitis(AH)seen during this period(2).This effect is postulated to be secondary to the psychosocial impact of the pandemic and increased alcohol sales during this time,which were evident in other regions including the United Kingdom(UK)(3).The lasting effects of the pandemic on ALD will be seen in the years to come,and public health measures aimed at patient advocacy and prevention are needed(4).
